litlas
ログインアカウント作成

Tero Aittokallio

1999–2026 年に発表

174
論文数
17,950
被引用数
73
h 指数
154
i10 指数

被引用数

Tero Aittokallio の年別被引用数1920 年: 被引用 2 件1981 年: 被引用 1 件1986 年: 被引用 2 件1993 年: 被引用 1 件1999 年: 被引用 3 件2000 年: 被引用 1 件2001 年: 被引用 2 件2002 年: 被引用 3 件2003 年: 被引用 3 件2004 年: 被引用 11 件2005 年: 被引用 5 件2006 年: 被引用 29 件2007 年: 被引用 34 件2008 年: 被引用 47 件2009 年: 被引用 58 件2010 年: 被引用 73 件2011 年: 被引用 65 件2012 年: 被引用 50 件2013 年: 被引用 71 件2014 年: 被引用 75 件2015 年: 被引用 135 件2016 年: 被引用 202 件2017 年: 被引用 209 件2018 年: 被引用 286 件2019 年: 被引用 647 件2020 年: 被引用 821 件2021 年: 被引用 1,057 件2022 年: 被引用 1,090 件2023 年: 被引用 823 件2024 年: 被引用 1,281 件2025 年: 被引用 783 件2026 年: 被引用 135 件1921〜1980 年は被引用が無いため表示していません1982〜1985 年は被引用が無いため表示していません1987〜1992 年は被引用が無いため表示していません1994〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,230 件、この内訳の 21.5%中国: 引用元論文 1,563 件、この内訳の 15.1%イギリス: 引用元論文 582 件、この内訳の 5.6%ドイツ: 引用元論文 569 件、この内訳の 5.5%フィンランド: 引用元論文 458 件、この内訳の 4.4%イタリア: 引用元論文 335 件、この内訳の 3.2%カナダ: 引用元論文 297 件、この内訳の 2.9%フランス: 引用元論文 293 件、この内訳の 2.8%インド: 引用元論文 265 件、この内訳の 2.6%オーストラリア: 引用元論文 239 件、この内訳の 2.3%スウェーデン: 引用元論文 231 件、この内訳の 2.2%スペイン: 引用元論文 223 件、この内訳の 2.2%
0%21.5%その他 29.7%

機関

分野

  • Biochemistry, Genetics and Molecular Biology34.6%
  • Medicine27.9%
  • Computer Science26%
  • Immunology and Microbiology3.4%
  • Chemistry1.6%
  • Engineering1%
  • その他5.5%

トピック

  • Computational Drug Discovery Methods9.4%
  • Bioinformatics and Genomic Networks5.6%
  • Gene expression and cancer classification2.7%
  • Protein Structure and Dynamics2.2%
  • Machine Learning in Bioinformatics1.9%
  • Cancer Genomics and Diagnostics1.9%
  • その他76.3%

共著者

全論文

検索で開く
  1. Making Sense of Large-Scale Kinase Inhibitor Bioactivity Data Sets: A Comparative and Integrative Analysis

    著者: Jing Tang, Agnieszka Szwajda, Sushil Kumar Shakyawar, Tao Xu, Petteri Hintsanen, Krister Wennerberg, Tero Aittokallio - Journal of Chemical Information and Modeling, J. Chem. Inf. Model. 2014 被引用: 629

  2. SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples

    著者: Aleksandr Ianevski, Anil K. Giri, Tero Aittokallio - Nucleic Acids Research, Nucleic Acids Res. 2022 被引用: 735

  3. Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data

    著者: Aleksandr Ianevski, Anil K. Giri, Tero Aittokallio - Nature Communications 2022 被引用: 785

  4. Searching for Drug Synergy in Complex Dose–Response Landscapes Using an Interaction Potency Model

    著者: Bhagwan Yadav, Krister Wennerberg, Tero Aittokallio, Jing Tang - Computational and Structural Biotechnology Journal 2015 被引用: 878

  5. Toward more realistic drug-target interaction predictions

    著者: Tapio Pahikkala, Antti Airola, Sami Pietilä, Sushil Kumar Shakyawar, Agnieszka Szwajda, Jing Tang, Tero Aittokallio - Briefings in Bioinformatics, Briefings Bioinform. 2014 被引用: 560

  6. SynergyFinder 2.0: visual analytics of multi-drug combination synergies

    著者: Aleksandr Ianevski, Anil K. Giri, Tero Aittokallio - Nucleic Acids Research, Nucleic Acids Res. 2020 被引用: 948

  7. SynergyFinder: a web application for analyzing drug combination dose-response matrix data

    著者: Aleksandr Ianevski, Liye He, Tero Aittokallio, Jing Tang - Bioinformatics, Bioinform. 2017 被引用: 569

  8. A community effort to assess and improve drug sensitivity prediction algorithms

    著者: NCI DREAM Community, James C. Costello, Laura M. Heiser, Elisabeth Georgii, Mehmet Gönen, Michael P. Menden, Nicholas J. Wang, Mukesh Bansal, Muhammad Ammad-ud-din, Petteri Hintsanen, Suleiman A. Khan, John-Patrick Mpindi, Olli Kallioniemi, Antti Honkela, Tero Aittokallio, Krister Wennerberg, James J Collins, Dan Gallahan, Dinah S. Singer, Julio Sáez-Rodríguez, Samuel Kaski, Joe W. Gray, Gustavo Stolovitzky - Nature Biotechnology 2014 被引用: 832

  9. Artificial intelligence, machine learning, and drug repurposing in cancer

    著者: Ziaurrehman Tanoli, Markus Vähä‐Koskela, Tero Aittokallio - Expert Opinion on Drug Discovery 2021 被引用: 214

  10. Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity

    著者: Olli Dufva, Jan Koski, Pilvi Maliniemi, Aleksandr Ianevski, Jay Klievink, Judith Leitner, Petri Pölönen, Helena Hohtari, Khalid Saeed, Tiina Hannunen, Pekka Ellonen, Peter Steinberger, Matti Kankainen, Tero Aittokallio, Mikko Keränen, Matti Korhonen, Satu Mustjoki - Blood 2019 被引用: 220

  11. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

    著者: Michael P. Menden, Dennis Wang, Mike J. Mason, Bence Szalai, Krishna C. Bulusu, Yuanfang Guan, Thomas Yu, Jaewoo Kang, Minji Jeon, Russ Wolfinger, Tin Nguyen, Mikhail Zaslavskiy, Jordi Abante, Barbara Schmitz Abecassis, Nanne Aben, Delasa Aghamirzaie, Tero Aittokallio, Farida S. Akhtari, Bissan Al‐Lazikani, Tanvir Alam, Amin Allam, Chad H. G. Allen, Mariana Pelicano de Almeida, Doaa Altarawy, Vinícius M. Alves, Alicia Amadoz, Benedict Anchang, Albert A. Antolín, Jeremy R. Ash, V. Aznar, Wail Ba-Alawi, Moeen Bagheri, Vladimir B. Bajić, G. C. Ball, Pedro J. Ballester, Delora Baptista, Christopher Bare, Mathilde Bateson, Andreas Bender, Denis Bertrand, Bhagya K. Wijayawardena, Keith A. Boroevich, Evert Bosdriesz, Salim Bougouffa, Gergana Bounova, Thomas Brouwer, Barbara M. Bryant, Manuel Calaza, Alberto Calderone, Stefano Calza, Stephen J. Capuzzi, José Carbonell‐Caballero, Daniel Carlin, Hannah Carter, Luisa Castagnoli, Remzi Çelebi, Gianni Cesareni, Hyeokyoon Chang, Guocai Chen, Hao Chen, Huiyuan Chen, Lijun Cheng, Ariel Chernomoretz, Davide Chicco, Kwang‐Hyun Cho, Sung‐Hwan Cho, Daeseon Choi, Jaejoon Choi, Kwanghun Choi, Minsoo Choi, Martine De Cock, Elizabeth A. Coker, Isidro Cortés‐Ciriano, Miklós Cserző, Cankut Çubuk, Christina Curtis, Dries Van Daele, Cuong Cao Dang, Tjeerd M. H. Dijkstra, Joaquı́n Dopazo, Sorin Drăghici, Anastasios Drosou, Michel Dumontier, Friederike Ehrhart, Fatma-Elzahraa Eid, Mahmoud ElHefnawi, Haitham Elmarakeby, Bo van Engelen, H. Billur Engin, Iwan J. P. de Esch, Chris T. Evelo, André O. Falcão, Sherif S. Farag, Carlos Fernandez-Lozano, Kathleen M. Fisch, Åsmund Flobak, Chiara Fornari, Amir Foroushani, Donatien Chedom Fotso, Denis Fourches ほか 254 名 - Nature Communications 2019 被引用: 363

  12. Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities

    著者: Mona Meng Wang, Sarah E. Coupland, Tero Aittokallio, Carlos R. Figueiredo - British Journal of Cancer 2023 被引用: 97

  13. Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

    著者: Disha Malani, Ashwini Kumar, Oscar Brück, Mika Kontro, Bhagwan Yadav, Monica Hellesøy, Heikki Kuusanmäki, Olli Dufva, Matti Kankainen, Samuli Eldfors, Swapnil Potdar, Jani Saarela, Laura Turunen, Alun Parsons, Imre Västrik, Katja Kivinen, Janna Saarela, Riikka Räty, Minna Lehto, Maija Wolf, Bjørn Tore Gjertsen, Satu Mustjoki, Tero Aittokallio, Krister Wennerberg, Caroline A. Heckman, Olli Kallioniemi, Kimmo Porkka - Cancer Discovery 2021 被引用: 198

  14. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products

    著者: Milla Kibble, Niina Saarinen, Jing Tang, Krister Wennerberg, Sari Mäkelä, Tero Aittokallio - Natural Product Reports 2015 被引用: 516

  15. Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

    著者: Bhagwan Yadav, Tea Pemovska, Agnieszka Szwajda, Evgeny Kulesskiy, Mika Kontro, Riikka Karjalainen, Muntasir Mamun Majumder, Disha Malani, Astrid Murumägi, Jonathan C. Knowles, Kimmo Porkka, Caroline A. Heckman, Olli Kallioniemi, Krister Wennerberg, Tero Aittokallio - Scientific Reports 2014 被引用: 369

  16. Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects

    著者: Heli Julkunen, Anna Cichońska, Prson Gautam, Sándor Szedmák, Jane Douat, Tapio Pahikkala, Tero Aittokallio, Juho Rousu - Nature Communications 2020 被引用: 151

  17. Prediction of drug combination effects with a minimal set of experiments

    著者: Aleksandr Ianevski, Anil K. Giri, Prson Gautam, Alexander Kononov, Potdar Swapnil, Saarela Jani, Krister Wennerberg, Tero Aittokallio - Nature Machine Intelligence, Nat. Mach. Intell. 2019 被引用: 188

  18. Systematic review of computational methods for drug combination prediction

    著者: Weikaixin Kong, Gianmarco Midena, Yingjia Chen, Paschalis Athanasiadis, Tianduanyi Wang, Juho Rousu, Liye He, Tero Aittokallio - Computational and Structural Biotechnology Journal 2022 被引用: 64

  19. Machine learning and feature selection for drug response prediction in precision oncology applications

    著者: Mehreen Ali, Tero Aittokallio - Biophysical Reviews 2018 被引用: 220

  20. Graph-based methods for analysing networks in cell biology

    著者: Tero Aittokallio, Benno Schwikowski - Briefings in Bioinformatics, Briefings Bioinform. 2006 被引用: 435

  21. Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths

    著者: Maija Ruuth, Su Duy Nguyen, Terhi Vihervaara, Mika Hilvo, Teemu D. Laajala, Pradeep Kumar Kondadi, Anton Gisterå, Hanna Lähteenmäki, Tiia Kittilä, Jenni Huusko, Matti Uusitupa, Ursula Schwab, Markku J. Savolainen, Juha Sinisalo, Marja‐Liisa Lokki, Markku S. Nieminen, Antti Jula, Markus Perola, Seppo Ylä‐Herttuala, Lawrence L. Rudel, Anssi Öörni, Marc Baumann, Amos Baruch, Reijo Laaksonen, Daniel F.J. Ketelhuth, Tero Aittokallio, Matti Jauhiainen, Reijo Käkelä, Jan Borén, Kevin Jon Williams, Petri T. Kovanen, Katariina Öörni - European Heart Journal 2018 被引用: 184

  22. Computational drug repurposing: approaches, evaluation of in silico resources and case studies

    著者: Ziaurrehman Tanoli, Adrià Fernández‐Torras, Umut Onur Özcan, A. Kushnir, Kristen Nader, Yojana Gadiya, L. Fiorenza, Aleksandr Ianevski, Markus Vähä‐Koskela, Mitro Miihkinen, Umair Seemab, Henri Leinonen, Brinton Seashore‐Ludlow, Marianna Tampere, Adelinn Kalman, Flavio Ballante, Emilio Benfenati, Gary Saunders, Swapnil Potdar, I. Garcia, Ricard García-Serna, Carmine Talarico, Andrea R. Beccari, Wesley Schaal, Andrea Polo, Susan Costantini, Enrico Cabri, Marc Jacobs, Jani Saarela, Alfredo Budillon, Ola Spjuth, Päivi Östling, Henri Xhaard, Jordi Quintana, Jordi Mestres, Philip Gribbon, Antón Ussi, Donald C. Lo, Martin de Kort, Krister Wennerberg, Maddalena Fratelli, Jordi Carreras‐Puigvert, Tero Aittokallio - Nature Reviews Drug Discovery 2025 被引用: 72

  23. What is synergy? The Saariselkä agreement revisited

    著者: Jing Tang, Krister Wennerberg, Tero Aittokallio - Frontiers in Pharmacology 2015 被引用: 221

  24. A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer

    著者: Alex H. Wagner, Brian Walsh, Georgia Mayfield, David Tamborero, Dmitriy Sonkin, Kilannin Krysiak, Jordi Deu-Pons, Ryan P. Duren, Jianjiong Gao, Julie A. McMurry, Sara E. Patterson, Catherine Del Vecchio Fitz, Beth A. Pitel, Ozman U. Sezerman, Kyle Ellrott, Jeremy L. Warner, Damian Rieke, Tero Aittokallio, Ethan Cerami, Deborah Ritter, Lynn M. Schriml, Robert R. Freimuth, Melissa Haendel, Gordana Raca, Subha Madhavan, Michael Baudis, J. Beckmann, Rodrigo Dienstmann, Debyani Chakravarty, Xuan Shirley Li, Susan M. Mockus, Olivier Elemento, Nikolaus Schultz, Núria López-Bigas, Mark Lawler, Jeremy Goecks, Malachi Griffith, Obi L. Griffith, Adam A. Margolin - Nature Genetics 2020 被引用: 176